XML 48 R31.htm IDEA: XBRL DOCUMENT
v3.22.4

Quarterly Results of Operations (unaudited) | 12 Months Ended
--- | ---
Dec. 31, 2022
Quarterly Financial Data [Abstract] |
Quarterly Results of Operations (unaudited) | Quarterly Results of Operations (unaudited) The unaudited consolidated quarterly results of operations (in thousands, except per share data) were as follows:
| For the Three Months Ended
| December 31 |  | September 30 |  | June 30 |  | March 31
2022 |  |  |  |  |  |  |
Total revenue | $ | 382,432 |  |  | $ | 352,585 |  |  | $ | 319,939 |  |  | $ | 297,057 |
Total operating expenses | 384,310 |  | 339,634 |  | 324,572 |  | 299,855
Net income (loss) from continuing operations | (11,349) |  | 2,123 |  | (4,125) |  | (5,350)
Net loss from discontinued operations, net of tax | — |  |  | — |  |  | (463) |  |  | — |
Net income (loss) attributable to common shareholders of Evolent Health, Inc. | (11,349) |  | 2,123 |  | (4,588) |  | (5,350)
Income (loss) per common share |  |  |  |  |  |  |
Basic and diluted |  |  |  |  |  |  |
| For the Three Months Ended
| December 31 |  | September 30 |  | June 30 |  | March 31
Continuing operations | $ | (0.11) |  |  | $ | 0.02 |  |  | $ | (0.05) |  |  | $ | (0.06) |
Discontinued operations | — |  |  | — |  |  | — |  |  | — |
2021 |  |  |  |  |  |  |
Total revenue | $ | 248,358 |  |  | $ | 222,471 |  |  | $ | 222,057 |  |  | $ | 215,071 |
Total operating expenses | 260,572 |  | 229,052 |  | 229,728 |  | 231,016
Net income (loss) from continuing operations | 3,053 |  | (13,040) |  | (9,107) |  | (11,190)
Net income (loss) from discontinued operations, net of tax | (8,700) |  | — |  |  | — |  |  | 1,383
Net loss attributable to common shareholders of Evolent Health, Inc. | (5,647) |  | (13,040) |  | (9,107) |  | (9,807)
Income (loss) per common share |  |  |  |  |  |  |
Basic and diluted |  |  |  |  |  |  |
Continuing operations | $ | 0.03 |  |  | $ | (0.15) |  |  | $ | (0.11) |  |  | $ | (0.13) |
Discontinued operations | (0.09) |  |  | — |  |  | — |  |  | 0.01 |

X
- References No definition available. + Details
Name: | us-gaap_QuarterlyFinancialDataAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -URI https://asc.fasb.org/topic&trid=2126967 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 50 -Paragraph 1B -URI https://asc.fasb.org/extlink&oid=126900988&loc=SL124452896-108306 + Details
Name: | us-gaap_QuarterlyFinancialInformationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration